Electronic health record (EHR)-based PROMIS measures among neurology clinic decedents and survivors: a retrospective cohort analysis

Abstract Background In addition to their standard use to assess real-time symptom burden, patient-reported outcomes (PROs), such as the Patient-Reported Outcomes Measurement Information System (PROMIS), measures offer a potential opportunity to understand when patients are experiencing meaningful cl...

Full description

Bibliographic Details
Main Authors: Natalie C. Ernecoff, Rebecca Weir, Anthony Rodriguez, Lucy B. Schulson, Maria Orlando Edelen, Janel Hanmer
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Health and Quality of Life Outcomes
Online Access:https://doi.org/10.1186/s12955-023-02176-0
_version_ 1797556307728793600
author Natalie C. Ernecoff
Rebecca Weir
Anthony Rodriguez
Lucy B. Schulson
Maria Orlando Edelen
Janel Hanmer
author_facet Natalie C. Ernecoff
Rebecca Weir
Anthony Rodriguez
Lucy B. Schulson
Maria Orlando Edelen
Janel Hanmer
author_sort Natalie C. Ernecoff
collection DOAJ
description Abstract Background In addition to their standard use to assess real-time symptom burden, patient-reported outcomes (PROs), such as the Patient-Reported Outcomes Measurement Information System (PROMIS), measures offer a potential opportunity to understand when patients are experiencing meaningful clinical decline. If PROs can be used to assess decline, such information can be used for informing medical decision making and determining patient-centered treatment pathways. We sought to use clinically implemented PROMIS measures to retrospectively characterize the final PROMIS report among all patients who completed at least one PROMIS assessment from December 2017-March 2020 in one large health system, stratified by decedents vs. survivors. We conducted a retrospective cohort analysis of decedents (N = 1,499) who received care from outpatient neurology clinical practice within a single, large health system as part of usual care. We also compared decedents to survivors (360 + days before death; N = 49,602) on PROMIS domains and PROMIS-Preference (PROPr) score, along with demographics and clinical characteristics. We used electronic health record (EHR) data with built-in PROMIS measures. Linear regressions assessed differences in PROMIS domains and aggregate PROPr score by days before death of the final PROMIS completion for each patient. Results Among decedents in our sample, in multivariable regression, only fatigue (range 54.48–59.38, p < 0.0029) and physical function (range 33.22–38.38, p < 0.0001) demonstrated clinically meaningful differences across time before death. The overall PROPr score also demonstrated statistically significant difference comparing survivors (0.19) to PROPr scores obtained 0–29 days before death (0.29, p < 0.0001). Conclusions Although clinic completion of PROMIS measures was near universal, very few patients had more than one instance of PROMIS measures reported, limiting longitudinal analyses. Therefore, patient-reported outcomes in clinical practice may not yet be robust enough for incorporation in prediction models and assessment of trajectories of decline, as evidenced in these specialty clinics in one health system. PROMIS measures can be used to effectively identify symptoms and needs in real time, and robust incorporation into EHRs can improve patient-level outcomes, but further work is needed for them to offer meaningful inputs for defining patient trajectories near the end of life. Plain English Summary Assessing symptom burden provides an opportunity to understand clinical decline, particularly as people approach the end of life. We sought to understand whether symptoms reported by patients can be used to assess decline in health. Such information can inform decision-making about care and treatments. Of eight symptoms that we assessed, patient reports of fatigue and physical function were associated with clinical decline, as was an overall score of symptom burden. Because few symptoms were associated with decline, patient-reported outcomes in clinical practice may not yet be robust enough for incorporation in prediction models and assessment of trajectories of decline.
first_indexed 2024-03-10T17:00:01Z
format Article
id doaj.art-8c02ed7dfd754025ad2628fe7dcb3d54
institution Directory Open Access Journal
issn 1477-7525
language English
last_indexed 2024-03-10T17:00:01Z
publishDate 2023-08-01
publisher BMC
record_format Article
series Health and Quality of Life Outcomes
spelling doaj.art-8c02ed7dfd754025ad2628fe7dcb3d542023-11-20T11:00:08ZengBMCHealth and Quality of Life Outcomes1477-75252023-08-012111610.1186/s12955-023-02176-0Electronic health record (EHR)-based PROMIS measures among neurology clinic decedents and survivors: a retrospective cohort analysisNatalie C. Ernecoff0Rebecca Weir1Anthony Rodriguez2Lucy B. Schulson3Maria Orlando Edelen4Janel Hanmer5RAND CorporationRAND CorporationRAND CorporationRAND CorporationRAND CorporationDivision of General Internal Medicine, School of Medicine, University of PittsburghAbstract Background In addition to their standard use to assess real-time symptom burden, patient-reported outcomes (PROs), such as the Patient-Reported Outcomes Measurement Information System (PROMIS), measures offer a potential opportunity to understand when patients are experiencing meaningful clinical decline. If PROs can be used to assess decline, such information can be used for informing medical decision making and determining patient-centered treatment pathways. We sought to use clinically implemented PROMIS measures to retrospectively characterize the final PROMIS report among all patients who completed at least one PROMIS assessment from December 2017-March 2020 in one large health system, stratified by decedents vs. survivors. We conducted a retrospective cohort analysis of decedents (N = 1,499) who received care from outpatient neurology clinical practice within a single, large health system as part of usual care. We also compared decedents to survivors (360 + days before death; N = 49,602) on PROMIS domains and PROMIS-Preference (PROPr) score, along with demographics and clinical characteristics. We used electronic health record (EHR) data with built-in PROMIS measures. Linear regressions assessed differences in PROMIS domains and aggregate PROPr score by days before death of the final PROMIS completion for each patient. Results Among decedents in our sample, in multivariable regression, only fatigue (range 54.48–59.38, p < 0.0029) and physical function (range 33.22–38.38, p < 0.0001) demonstrated clinically meaningful differences across time before death. The overall PROPr score also demonstrated statistically significant difference comparing survivors (0.19) to PROPr scores obtained 0–29 days before death (0.29, p < 0.0001). Conclusions Although clinic completion of PROMIS measures was near universal, very few patients had more than one instance of PROMIS measures reported, limiting longitudinal analyses. Therefore, patient-reported outcomes in clinical practice may not yet be robust enough for incorporation in prediction models and assessment of trajectories of decline, as evidenced in these specialty clinics in one health system. PROMIS measures can be used to effectively identify symptoms and needs in real time, and robust incorporation into EHRs can improve patient-level outcomes, but further work is needed for them to offer meaningful inputs for defining patient trajectories near the end of life. Plain English Summary Assessing symptom burden provides an opportunity to understand clinical decline, particularly as people approach the end of life. We sought to understand whether symptoms reported by patients can be used to assess decline in health. Such information can inform decision-making about care and treatments. Of eight symptoms that we assessed, patient reports of fatigue and physical function were associated with clinical decline, as was an overall score of symptom burden. Because few symptoms were associated with decline, patient-reported outcomes in clinical practice may not yet be robust enough for incorporation in prediction models and assessment of trajectories of decline.https://doi.org/10.1186/s12955-023-02176-0
spellingShingle Natalie C. Ernecoff
Rebecca Weir
Anthony Rodriguez
Lucy B. Schulson
Maria Orlando Edelen
Janel Hanmer
Electronic health record (EHR)-based PROMIS measures among neurology clinic decedents and survivors: a retrospective cohort analysis
Health and Quality of Life Outcomes
title Electronic health record (EHR)-based PROMIS measures among neurology clinic decedents and survivors: a retrospective cohort analysis
title_full Electronic health record (EHR)-based PROMIS measures among neurology clinic decedents and survivors: a retrospective cohort analysis
title_fullStr Electronic health record (EHR)-based PROMIS measures among neurology clinic decedents and survivors: a retrospective cohort analysis
title_full_unstemmed Electronic health record (EHR)-based PROMIS measures among neurology clinic decedents and survivors: a retrospective cohort analysis
title_short Electronic health record (EHR)-based PROMIS measures among neurology clinic decedents and survivors: a retrospective cohort analysis
title_sort electronic health record ehr based promis measures among neurology clinic decedents and survivors a retrospective cohort analysis
url https://doi.org/10.1186/s12955-023-02176-0
work_keys_str_mv AT nataliecernecoff electronichealthrecordehrbasedpromismeasuresamongneurologyclinicdecedentsandsurvivorsaretrospectivecohortanalysis
AT rebeccaweir electronichealthrecordehrbasedpromismeasuresamongneurologyclinicdecedentsandsurvivorsaretrospectivecohortanalysis
AT anthonyrodriguez electronichealthrecordehrbasedpromismeasuresamongneurologyclinicdecedentsandsurvivorsaretrospectivecohortanalysis
AT lucybschulson electronichealthrecordehrbasedpromismeasuresamongneurologyclinicdecedentsandsurvivorsaretrospectivecohortanalysis
AT mariaorlandoedelen electronichealthrecordehrbasedpromismeasuresamongneurologyclinicdecedentsandsurvivorsaretrospectivecohortanalysis
AT janelhanmer electronichealthrecordehrbasedpromismeasuresamongneurologyclinicdecedentsandsurvivorsaretrospectivecohortanalysis